UOB Kay Hian

Stay informed with us

By subscribing, you agree to receive research insights and marketing communications from us. You may unsubscribe at any time. See our Privacy Policy for details.

Sino Biopharmaceutical (1177 HK): 1H26: Results In Line; Innovative Products Continue To Drive Growth | Research | UOB Kay Hian Hong Kong